0001213900-16-016819.txt : 20160915 0001213900-16-016819.hdr.sgml : 20160915 20160915170709 ACCESSION NUMBER: 0001213900-16-016819 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160915 DATE AS OF CHANGE: 20160915 EFFECTIVENESS DATE: 20160915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DanDrit Biotech USA, Inc. CENTRAL INDEX KEY: 0001527728 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452259340 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-270777 FILM NUMBER: 161887730 BUSINESS ADDRESS: STREET 1: DANDRIT BIOTECH A/S STREET 2: FRUEBJERGVEJ 3 BOX 62 CITY: 2100 COPENHAGEN STATE: G7 ZIP: 0 BUSINESS PHONE: 45 39179840 MAIL ADDRESS: STREET 1: DANDRIT BIOTECH A/S STREET 2: FRUEBJERGVEJ 3 BOX 62 CITY: 2100 COPENHAGEN STATE: G7 ZIP: 0 FORMER COMPANY: FORMER CONFORMED NAME: Putnam Hills Corp. DATE OF NAME CHANGE: 20110810 D 1 primary_doc.xml X0707 D LIVE 0001527728 DanDrit Biotech USA, Inc. FRUEBJERGVEJ 3 BOX 62 COPENHAGEN G7 DENMARK 2100 (453) 917-9840 DELAWARE None Putnam Hills Corp. Corporation true Eric Leire Fruebjergvej 3 Box 62 Copenhagen G7 DENMARK 2100 Executive Officer Director N. E. Nielsen Fruebjergvej 3 Box 62 Copenhagen G7 DENMARK 2100 Director Aldo Michael Noes Petersen Fruebjergvej 3 Box 62 Copenhagen G7 DENMARK 2100 Director Biotechnology Decline to Disclose 06b false true false true true On 4/4/16 Issuer entered into an asset purchase agreement with OncoSynergy -see 8-K filed 4/5/16. Purchase price consists of common stock outstanding prior to closing and derivative securities; acquisition subject to approval by Issuer shareholders. 10000 Livingston Securities, LLC 147364 None None 825 THIRD AVENUE, SECOND FLOOR NEW YORK NY NEW YORK 10022 All States false 16500000 0 16500000 false 0 50000 true 0 0 false DanDrit Biotech USA, Inc. /s/ Dr. Eric Leire Dr. Eric Leire Chief Executive Officer 2016-09-15